BioSpace News Archive

NeuroRx, a clinical stage biopharma company focused on the development of Rapid Acting Antidepressants (RAADs) that target the brain’s NMDA receptor, has been granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA) for development of NRX-101

Prime Healthcare owns and operates 45 acute care hospitals in 14 states.

Notes With 50% Warrants Exercisable at $0.35 Per Share

Kleo Pharmaceuticals Inc., announced the closing of an oversubscribed $21 million Series B financing to advance its first clinical candidates through IND-enabling studies and into the clinic in 2020.

The Mesothelioma Victims Center is appealing to a shipyard worker or Navy Veteran who has recently been diagnosed with mesothelioma and inviting them, or their family, to call them anytime at 800-714-0303.

Shandong completed the last of its $1 million dollars in payments to Guided Therapeutics under the terms of the agreement between the two companies.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that the company has been awarded a contract for iQ-Check real-time PCR pathogen detection test kits and the iQ-Check Prep Automation System from the United States Department of Agriculture’s Food Safety and Inspection Service (USDA FSIS).

Optical character recognition technology eliminates privacy breaches, exclusive to healthcare providers partnering with MRO

WHO World Antibiotic Awareness week 2018 [12-18 November]

Acessa Health Inc., developer of the Acessa System®, announced today that its laparoscopic radiofrequency ablation technology was featured at the 47th American Association of Gynecologic Laparoscopists (AAGL) Global Congress on Minimally Invasive Gynecologic Surgery (MIGS).